Stanford Peng

Stanford Peng

Private Equity Investor at
Frazier Management LLC
55 year
Health Technology
Consumer Services
Finance

Profile

Stanford L.
Peng
is currently a Venture Partner at Frazier Management LLC since 2025.
Former positions include President, Head-Research & Development at Alpine Immune Sciences, Inc. from 2019 to 2024; Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016; Executive Director-Medical at Seagen, Inc. from 2014 to 2015; Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014; Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009; and Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Education includes undergraduate studies at Stanford University and a doctorate from Yale School of Medicine.

Stanford Peng active positions

CompaniesPositionStart
Private Equity Investor 2024-12-31

Former positions of Stanford Peng

CompaniesPositionEnd
ALPINE IMMUNE SCIENCES, INC. President 2024-05-19
Chief Tech/Sci/R&D Officer 2015-12-31
SEAGEN INC. Chief Tech/Sci/R&D Officer 2014-12-31
Chief Tech/Sci/R&D Officer 2013-12-31
ARYX THERAPEUTICS, INC. Director/Board Member 2008-12-31
See the detail of Stanford Peng's experience

Training of Stanford Peng

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!